Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-07-06

FDA Approved: INFANTS ADVIL — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

The FDA approved a supplemental application for Infants Advil (ibuprofen) submitted by Haleon US Holdings LLC, updating labeling and indications for infant use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INFANTS ADVIL (Ibuprofen)

Snippet

SUPPL AP for INFANTS ADVIL (IBUPROFEN)